Inhaled beclomethasone (BDP) with non-CFC propellant (HFA 134a) is equivalent to BDP-CFC for the treatment of asthma
- 1 April 1999
- journal article
- clinical trial
- Published by Elsevier in Respiratory Medicine
- Vol. 93 (4) , 245-251
- https://doi.org/10.1016/s0954-6111(99)90020-3
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Hydrofluoroalkane-134a beclomethasone dipropionate extrafine aerosol provides equivalent asthma control to chlorofluorocarbon beclomethasone dipropionate at approximately half the total daily doseRespiratory Medicine, 1998
- Safety of hydrofluoroalkane-134a beclomethasone dipropionate extrafine aerosolRespiratory Medicine, 1998
- EQUIVALENCE OF ASTHMA CONTROL WITH NEW CFC‐FREE FORMULATION HFA‐134a BECLOMETHASONE DIPROPIONATE AND CFC‐BECLOMETHASONE DIPROPIONATEInternational Journal Of Clinical Practice, 1997
- PHARMACOKINETICS OF HFA-134aClinical Journal of Sport Medicine, 1996
- Twenty-eight-day Double-blind Safety Study of an HFA-134a Inhalation Aerosol System in Healthy SubjectsJournal of Pharmacy and Pharmacology, 1996
- Cumulative Dose-Response Study of Non-CFC Propellant HFA 134a Salbutamol Sulfate Metered-Dose Inhaler in Patients With AsthmaChest, 1996
- Clinical Pharmacology of HFA134aJournal of Aerosol Medicine, 1995